# Filing Detail

Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001628280-24-044110
Filing Date
2024-10-29
Accepted
2024-10-29 16:32:57
Documents
14
Period of Report
2024-10-21

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | PRE 14A | alts-20241029.htm iXBRL | PRE 14A | 548113
3 |  | alts-20241029_g1.jpg | GRAPHIC | 114852
4 |  | alts-20241029_g2.jpg | GRAPHIC | 132943
| Complete submission text file | 0001628280-24-044110.txt |  | 1572443

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
2 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | alts-20241029.xsd | EX-101.SCH | 926
16 | EXTRACTED XBRL INSTANCE DOCUMENT | alts-20241029_htm.xml | XML | 33732

Mailing Address 325 E. WARM SPRINGS ROAD SUITE 102 LAS VEGAS NV 89119
Business Address 325 E. WARM SPRINGS ROAD SUITE 102 LAS VEGAS NV 89119 702-997-5968
ALT5 Sigma Corp (Filer) CIK: 0000862861 (see all company filings)

EIN.: 411454591 | State of Incorp.: NV | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 000-19621 | Film No.: 241406239
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)